Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 10.90 |
---|---|
High | 11.10 |
Low | 10.43 |
Bid | 10.47 |
Offer | 10.48 |
Previous close | 10.95 |
Average volume | 2.20m |
---|---|
Shares outstanding | 160.88m |
Free float | 119.70m |
P/E (TTM) | -- |
Market cap | 1.76bn USD |
EPS (TTM) | -0.4935 USD |
Data delayed at least 15 minutes, as of Sep 16 2024 17:51 BST.
More ▼
- Certara to Participate in Upcoming Investor Conferences
- Certara Launches Phoenix™ Version 8.5 Drug Development Software
- Certara Reports Second Quarter 2024 Financial Results
- Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
- Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
- Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
- Certara to Participate in the Jefferies Global Healthcare Conference
- Certara Appoints New Chief Human Resources Officer & General Counsel
- Certara Reports First Quarter 2024 Financial Results
- Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
More ▼